Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
American Journal of Physiology. Renal Physiology|September 8, 2017
Acute blood loss stimulates fibroblast growth factor 23 productionSeham Rabadi, Ikemesit Udo, David E Leaf, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 16, 2012
FGF-23 levels in patients with AKI and risk of adverse outcomesDavid E Leaf, Myles Wolf, Sushrut S Waikar, et al.American Journal of Nephrology|September 15, 2016
Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient CohortsHanni Menn-Josephy, Carol S Lee, Angela Nolin, et al.Kidney International|May 10, 2013
Plasma FGF23 levels increase rapidly after acute kidney injuryMarta Christov, Sushrut S Waikar, Renata C Pereira, et al.Journal of the American Society of Nephrology : JASN|December 29, 2016
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical IllnessDavid E Leaf, Kirolos A Jacob, Anand Srivastava, et al.Endocrinology|March 22, 2017
Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 LevelsVanessa M Knab, Braden Corbin, Olena Andrukhova, et al.Kidney International|March 1, 2016
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgeryDavid E Leaf, Marta Christov, Harald Jüppner, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 18, 2014
TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib)Angelo Molinaro, Dov Tiosano, Rieko Takatani, et al.JCI Insight|February 23, 2018
Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalitiesMarta Christov, Abbe R Clark, Braden Corbin, et al.Journal of the American Society of Nephrology : JASN|February 10, 2019
Iron, Hepcidin, and Death in Human AKIDavid E Leaf, Mohan Rajapurkar, Suhas S Lele, et al.Pageof 3